JP2018534910A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018534910A5 JP2018534910A5 JP2018512289A JP2018512289A JP2018534910A5 JP 2018534910 A5 JP2018534910 A5 JP 2018534910A5 JP 2018512289 A JP2018512289 A JP 2018512289A JP 2018512289 A JP2018512289 A JP 2018512289A JP 2018534910 A5 JP2018534910 A5 JP 2018534910A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- seq
- methylation
- region
- mammal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1516971.7A GB201516971D0 (en) | 2015-09-25 | 2015-09-25 | MVD as epigenetic marker for the identification of immune cells, in particular CD56+ NK cells |
| GB1516971.7 | 2015-09-25 | ||
| PCT/EP2016/072522 WO2017050882A1 (en) | 2015-09-25 | 2016-09-22 | Mvd as epigenetic marker for the identification of immune cells, in particular cd56+ nk cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018534910A JP2018534910A (ja) | 2018-11-29 |
| JP2018534910A5 true JP2018534910A5 (https=) | 2019-10-31 |
Family
ID=54544101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018512289A Pending JP2018534910A (ja) | 2015-09-25 | 2016-09-22 | 免疫細胞、特にｃｄ５６＋ ｎｋ細胞の同定のためのエピジェネティックマーカーとしてのｍｖｄ |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11788141B2 (https=) |
| EP (1) | EP3353321B1 (https=) |
| JP (1) | JP2018534910A (https=) |
| CN (1) | CN108026577B (https=) |
| CA (1) | CA2995350A1 (https=) |
| GB (1) | GB201516971D0 (https=) |
| HK (1) | HK1257705A1 (https=) |
| WO (1) | WO2017050882A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102017125013B4 (de) * | 2017-10-25 | 2019-10-17 | Epiontis Gmbh | MCC als epigenetischer Marker zur Identifizierung von Immunzellen, insbesondere basophiler Granulozyten |
| DE102018112644B4 (de) * | 2018-05-25 | 2020-06-10 | Epiontis Gmbh | CXCR3 als epigenetischer Marker zur Identifizierung von inflammatorischen Immunzellen, insbesondere CD8+ Gedächnis-T-Zellen |
| DE102018116353B4 (de) * | 2018-07-05 | 2020-06-10 | Epiontis Gmbh | Verfahren zum Nachweis und zur Zählung epigenetischer Immunzellen in humanen Blutproben für Immundiagnostik und Neugeborenen-Screening |
| CN119372341B (zh) * | 2024-12-30 | 2025-04-11 | 北京致谱医学检验实验室有限公司 | 基于基因甲基化检测实现人nk淋巴细胞计数的试剂盒 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USH2220H1 (en) * | 2001-08-10 | 2008-07-01 | Snp Consortium | Identification and mapping of single nucleotide polymorphisms in the human genome |
| DK1826279T3 (da) * | 2006-02-28 | 2011-09-05 | Charite Universitaetsmedizin | Detektering og kvalitetskontrol af regulatoriske t-celler vha. DNA-metyleringsanalyse af FoxP3--genet |
| EP3093351B1 (en) * | 2008-07-09 | 2018-04-18 | Celera Corporation | Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof |
| EP2248913B1 (en) * | 2009-04-28 | 2016-10-05 | Epiontis GmbH | GNLY as epigenetic marker for the identification of CD56-expressing natural killer cells |
| CN102343086A (zh) * | 2010-05-28 | 2012-02-08 | 四川大学 | 治疗或预防肿瘤的药物、肿瘤全细胞疫苗及其制备方法和用途 |
| WO2012045888A1 (en) * | 2010-10-08 | 2012-04-12 | Epiontis Gmbh | Method for determining cancer patient survival based on analyzing tumor-infiltrating overall t-lymphocytes |
| GB201112586D0 (en) | 2011-07-22 | 2011-09-07 | Epiontis Gmbh | Epigenetic marker for the identification of natural killer cells |
| WO2013033627A2 (en) | 2011-09-01 | 2013-03-07 | The Regents Of The University Of California | Diagnosis and treatment of arthritis using epigenetics |
-
2015
- 2015-09-25 GB GBGB1516971.7A patent/GB201516971D0/en not_active Ceased
-
2016
- 2016-09-22 CN CN201680052340.6A patent/CN108026577B/zh active Active
- 2016-09-22 CA CA2995350A patent/CA2995350A1/en active Pending
- 2016-09-22 WO PCT/EP2016/072522 patent/WO2017050882A1/en not_active Ceased
- 2016-09-22 HK HK19100073.9A patent/HK1257705A1/zh unknown
- 2016-09-22 JP JP2018512289A patent/JP2018534910A/ja active Pending
- 2016-09-22 EP EP16770485.7A patent/EP3353321B1/en active Active
- 2016-09-22 US US15/752,048 patent/US11788141B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cetica et al. | Genetic predisposition to hemophagocytic lymphohistiocytosis: report on 500 patients from the Italian registry | |
| Jara-Acevedo et al. | Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications | |
| EP3327141B1 (en) | Method for identifying the quantitative cellular composition in a biological sample | |
| De Stefano et al. | Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders | |
| Halbritter et al. | Epigenomics and single-cell sequencing define a developmental hierarchy in Langerhans cell histiocytosis | |
| JP2018529345A5 (https=) | ||
| WO2007121276A3 (en) | Enrichment of circulating fetal dna | |
| JP2012511917A5 (https=) | ||
| Guarrera et al. | Peripheral blood DNA methylation as potential biomarker of malignant pleural mesothelioma in asbestos-exposed subjects | |
| Schulte-Schrepping et al. | Suppressive myeloid cells are a hallmark of severe COVID-19 | |
| JP2018529346A5 (https=) | ||
| JP2018534910A5 (https=) | ||
| EP3507601A1 (en) | Methods for the identification, targeting and isolation of human dendritic cell (dc) precursors "pre-dc" and their uses thereof | |
| Genshaft et al. | Clinical implementation of single-cell RNA sequencing using liver fine needle aspirate tissue sampling and centralized processing captures compartment specific immuno-diversity | |
| JP6113159B2 (ja) | ナチュラルキラー細胞を同定するエピジェネティックマーカー | |
| JP2021502806A5 (https=) | ||
| US10191055B2 (en) | Detection of acute myeloid leukaemia (AML) leukaemic stem cells (LSC) | |
| JP2021502809A5 (https=) | ||
| AU2006275302B2 (en) | Method for identifying regulatory T cells | |
| DI GANGI | SINGLE CELL BIOLOGY AS A NOVEL TOOL IN OSTEOSARCOMA RESEARCH: APPLICATION TO CHILDREN, ADOLESCENTS AND YOUNG ADULTS | |
| Alqatta et al. | The Crucial Function of Biomarkers in the Diagnosis and Management of Systemic Sclerosis-Associated Interstitial Lung Disease | |
| Coudert et al. | Isolation of Live Leukocytes from Human Inflammatory Muscles. Methods Protoc. 2021, 4, 75 | |
| Stirland et al. | DNA Methylation as a Biomarker of Gestational SARS-CoV-2 Exposure: Differential Methylation Patterns in Placental and Cord Blood Tissues Model Third Trimester COVID-19 | |
| Geng et al. | UBXN3B Restricts Viral Pathogenesis by Maintaining Hematopoietic Homeostasis | |
| ES2786778T3 (es) | Procedimiento para identificar la composición celular cuantitativa en una muestra biológica |